US FDA Formalizes ‘One-Trial’ Approach For Oncology Accelerated Approval

Neurology lab
OCE guidance says one or two randomized controlled trials could be sufficient to receive accelerated approval and confirm clinical benefit. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from R&D

More from Pink Sheet